Vascular Surgery Products

A line of products designed to provide a gentle approach to the treatment of vascular inflammation and infections, for care, topical and systemic treatment of ‘Circulatory and microcirculatory failure, venous stasis, edema, of Ulcers and of Diabetic Foot

All products of this line are constituted by an association of active ingredients, and optimal dosages to ensure a rapid therapeutic effect.









RSS Journal of Vascular Surgery

  • Journal of Vascular Surgery – February 2021 Audiovisual Summary February 1, 2021
    Hello! My name is Peter Lawrence and I am pleased to introduce the February issue of the Journal of Vascular Surgery and highlight four outstanding papers that are freely available for the next 2 months.
    Peter F. Lawrence
  • Editorial Board February 1, 2021
  • Information for Readers February 1, 2021
    Communications regarding original articles and editorial management should be addressed to Peter Gloviczki, MD, and Peter F. Lawrence, MD, Editors, Journal of Vascular Surgery, 9400 W. Higgins Road, Suite 315, Rosemont IL 60018; telephone: 312-334-2355; fax: 312-334-2320; e-mail: JVASCSURG@vascularsociety.org. Information for authors appears in the January and July issues, at www.jvascsurg.org, and at jvs.editorialmanager.com. Authors […]
  • Five Year Patient Outcomes of Endovascular Abdominal Aortic Aneurysm Repair in the ENDURANT France Registry February 1, 2021
    Endovascular repair is the preferred method of treatment for infrarenal abdominal aortic aneurysms with numerous publications from multiple geographic regions showing excellent patient outcomes. Since the original ACE (Anevrysme de l'aorte abdominale: Chirurgie versus Endoprothese) randomised control trial, studies of French specific population have also contributed significantly to the body of evidence in support of […]
    J.-P. Becquemin, S. Haupert, F. Issam, A. Dubar, Y. Martelloni, Y. Jousset, A. Sauguet
  • Long Term Outcomes of Endovascular Therapy for Failing Distal Bypass Vein Grafts February 1, 2021
    Although distal bypass using vein has been established with acceptable outcomes for chronic limb threatening ischaemia (CLTI), the major issue affecting long term outcomes is vein graft disease. This study aimed to analyse the peri-procedural results and long term outcomes of endovascular therapy (EVT) for failing vein grafts after distal bypass.
    T. Kobayashi, M. Hamamoto, T. Okazaki, M. Hasegawa, S. Takahashi
  • Rationale, Design, and Implementation of Intensive Risk Factor Treatment in the CREST2 Trial February 1, 2021
    A subanalysis of patients entered in the CREST2 trial (carotid revascularization and medical management for asymptomatic carotid stenosis) from 2014 to March 23, 2020 was performed.
    T. Turan, J.H. Voeks, M.I. Chimowitz
  • Heparin-Bonded Stent-Graft for the Treatment of TASC IIC and D Femoropopliteal Lesions: 36-Month Results of the Viabahn 25-cm Trial February 1, 2021
    A prospective, seven-center, single-arm, European Union trial (dates not provided) was performed.
    T. Bohme, E. Noory, K. Brechtel, D. Scheinert, M. Bosiers, U. Beschorner